Australian Clinical Labs Limited (ASX:ACL)
Australia flag Australia · Delayed Price · Currency is AUD
2.200
-0.020 (-0.90%)
Mar 6, 2026, 4:10 PM AEST

Australian Clinical Labs Company Description

Australian Clinical Labs Limited provides pathology diagnostic services in Australia.

The company offers range of services, including molecular cancer, harmony NIPT, genetic carrier screening and other antenatal, cardiac, and commercial drug and alcohol testing services; chemical pathology, haematology, histopathology and cytopathology, serology and microbiology, allergy and immunology, and veterinary and functional pathology services; pathology services for clinical trials; and CPD programs.

It serves doctors, patients, and corporate clients. The company was incorporated in 2020 and is headquartered in Clayton, Australia.

Australian Clinical Labs Limited
Country Australia
Founded 2020
Industry Diagnostics & Research
Sector Healthcare
Employees 4,700
CEO Melinda McGrath

Contact Details

Address:
1868-1892 Dandenong Road
Clayton, VIC 3168
Australia
Phone 61 1 3004 53688
Website clinicallabs.com.au

Stock Details

Ticker Symbol ACL
Exchange Australian Securities Exchange
Fiscal Year July - June
Reporting Currency AUD
ISIN Number AU0000148496
SIC Code 8071

Key Executives

Name Position
Darren McKee Chief Executive Officer of Victoria
Shae Seymour Chief Risk Officer and Chief Executive Officer of WA/SA/NT
Chris Brownlow Chief Executive Officer of New South Wales and Australian Capital Territory
Melinda McGrath Chief Executive Officer, MD and Executive Director
Matthew Cordingley Chief Financial Officer
Anthony Friedli Chief Operating Officer
Sean Jackson Chief Information Officer
Joe Geran National Marketing Director
Associate Prof. Tony Landgren National Medical Director and Chief Pathologist
Eleanor Padman B.A., FCIS Company Secretary